JPMORGAN CHASE & CO - ASTRIA THERAPEUTICS INC ownership

ASTRIA THERAPEUTICS INC's ticker is and the CUSIP is 04635X102. A total of 69 filers reported holding ASTRIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ASTRIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$129,334
-43.7%
17,337
-37.2%
0.00%
Q2 2023$229,850
+7561.7%
27,593
+9128.4%
0.00%
Q3 2022$3,0002990.00%
Other shareholders
ASTRIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Altium Capital Management LP 1,347,088$10,049,2765.24%
Saturn V Capital Management LP 1,219,093$9,094,4343.81%
Affinity Asset Advisors, LLC 1,000,300$7,462,2382.10%
Fairmount Funds Management LLC 1,901,397$14,184,4221.71%
Tri Locum Partners LP 598,128$4,462,0351.43%
Vivo Capital, LLC 1,681,199$12,541,7451.37%
SPHERA FUNDS MANAGEMENT LTD. 580,599$4,331,2690.79%
Ghost Tree Capital, LLC 300,000$2,238,0000.74%
DAFNA Capital Management LLC 295,493$2,204,3780.69%
Perceptive Advisors 2,189,462$16,333,3870.54%
View complete list of ASTRIA THERAPEUTICS INC shareholders